FAIRFIELD, Conn., June 30, 2014 /PRNewswire/ -- The
Calmare® Pain Therapy Device, the flagship product of
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI),
the pain mitigation company, gained a favorable reimbursement
ruling from the New York City Civil Courts in a personal injury
case against Allstate Insurance, Co., (Allstate). In the ruling,
the Court instructed the insurance giant to reimburse Forest
Rehabilitation Medicine P.C. (Forest) for its use of Calmare pain
therapy (Calmare) on patients who suffer pain as a result of car
accident injuries.
In the New York Civil Court case, Forest Rehabilitation
Medicine P.C. v. Allstate Insurance Company, New York Civil
Court Judge Theresa Ciccotto
rejected Allstate's claim that Calmare, which has been cleared by
the U.S. Food and Drug Administration (FDA), is an unproven method.
In granting the clinic's bid for the reimbursement, Judge Ciccotto
cited the FDA's approval of the treatment and said that she was not
concerned about a lack of studies on the long-term effects. This
was the first published decision in the U.S. involving the medical
necessity of Calmare therapy.
Forest, which has clinics in Staten
Island and Brooklyn, last
year became the first practice in the
United States certified in the treatment. Dominick Gullo of the New York-based law firm, Cassandra & Gullo
successfully litigated the case in behalf of Forest.
In the ruling, Judge Ciccotto stated: "It is common knowledge
that most if not every type of medication on the market has
potential adverse side effects. Anything new ... will inevitably
have 'kinks,' which need to be worked out over time. However, this
fact should not fuel any unreasonable fear or disapproval of a
device which has the potential to literally revolutionize how the
medical field addresses and combats chronic pain."
"Judge Ciccotto's decision may be the legal precedent our
Nation's chronic pain sufferers have been waiting for," said
Competitive Technologies President & CEO Conrad Mir. "Today, about 100 million Americans,
one-third of the Nation's population, are plagued by chronic pain.
This ruling may help make living pain-free a reality."
For more information on Calmare therapy treatments, please
visit: www.calmarett.com or download the Calmare App for iOS or
Android.
About Forest Rehabilitation Medicine P.C.
Forest
Rehabilitation Medicine P.C. (now known as Calmare Pain Relief
Solutions) is a Physician group which specializes in offering a
non-narcotic and non-invasive solution for chronic pain.
Christopher Perez, MD and
Jack D'Angelo, MD, the
physicians at Calmare Pain Relief Solutions, specialize in physical
medicine and rehabilitation. Together, they have over 30 years of
clinical experience treating chronic pain patients suffering from
neuropathies such as spinal radiculopathies,
post-surgical neuropathic pain, shingles, failed back
surgery, Reflex Sympathetic Dystrophy/Chronic Regional Pain
Syndrome (RSD/CRPS), and Chemotherapy-induced Peripheral Neuropathy
(CIPN).
About the Company
Competitive Technologies Inc., the
pain mitigation company, develops and commercializes innovative
wound and pain management products and technologies. CTI holds the
510k clearance on its flagship product, the non-invasive
Calmare® Pain Therapy Device. The Company is the
exclusive licensed global distributor of Calmare.
Forward-Looking Statement
Certain statements
contained in this press release are forward-looking statements that
involve risks and uncertainties. The statements contained herein
that are not purely historical are forward looking statements
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Forward-looking statements deal with the Company's current
plans, intentions, beliefs and expectations and statements of
future economic performance. Forward-looking statements involve
known and unknown risks and uncertainties that may cause the
Company's actual results in future periods to differ materially
from what is currently anticipated. Factors that could cause or
contribute to such differences include those discussed from time to
time in reports filed by the Company with the Securities and
Exchange Commission. The Company cannot guarantee its future
results, levels of activity, performance or achievements.
Contacts: |
|
Competitive
Technologies,
Inc.
|
JV Public
Relations
|
Conrad
Mir |
Janet
Vasquez
|
President and
CEO
|
Managing
Director
|
cmir@competitivetech.net |
jvasquez@jvprny.com
|
973.798.8882
|
212.645.5498
|
www.competitivetech.net
Logo -
http://photos.prnewswire.com/prnh/20131015/NY97852LOGO
SOURCE Competitive Technologies, Inc.